Delivering the message: Epimorphin and mammary epithelial morphogenesis

Trends in Cell Biology

Volumn 13, Issue 8, 2003, Pages 426-434

  Radisky, Derek C ^a   Hirai, Yohei ^b   Bissell, Mina J ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b SUMITOMO ELECTRIC INDUSTRIES LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; SYNTAXIN; SYNTAXIN 2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

BREAST EPITHELIUM; CELL DIVISION; CELL INTERACTION; CELL STRUCTURE; EXTRACELLULAR MATRIX; EXTRACELLULAR SPACE; INTRACELLULAR SPACE; MAMMARY GLAND; MESENCHYME CELL; MILK; MORPHOGENESIS; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN TRANSPORT; REVIEW;

MAMMALIA;

EID: 0041345990     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8924(03)00146-6     Document Type: Review

References (111)

1. Daniel C.W., Smith G.H. The mammary gland: a model for development. J. Mammary Gland Biol. Neoplasia. 4:1999;3-8.
2. Veltmaat J.M., et al. Mouse embryonic mammogenesis as a model for the molecular regulation of pattern formation. Differentiation. 71:2003;1-17.
3. Robinson G.W., et al. Regulation of mammary gland development by tissue interaction. J. Mammary Gland Biol. Neoplasia. 4:1999;9-19.
4. Humphreys R.C., et al. Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis. Development. 122:1996;4013-4022.
5. Debnath J., et al. The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell. 111:2002;29-40.
6. Dunbar M.E., Wysolmerski J.J. Mammary ductal and alveolar development: lesson learned from genetically manipulated mice. Microsc. Res. Tech. 52:2001;163-170.
7. Hovey R.C., et al. Establishing a framework for the functional mammary gland: from endocrinology to morphology. J. Mammary Gland Biol. Neoplasia. 7:2002;17-38.
8. Cunha G.R., et al. Elucidation of a role for stromal steroid hormone receptors in mammary gland growth and development using tissue recombinants. J. Mammary Gland Biol. Neoplasia. 2:1997;393-402.
9. Imagawa W., et al. Hormone/growth factor interactions mediating epithelial/stromal communication in mammary gland development and carcinogenesis. J. Steroid Biochem. Mol. Biol. 80:2002;213-230.
10. Kamalati T., et al. HGF/SF in mammary epithelial growth and morphogenesis: in vitro and in vivo models. J. Mammary Gland Biol. Neoplasia. 4:1999;69-77.
11. Silberstein G.B. Tumour-stromal interactions. Role of the stroma in mammary development. Breast Cancer Res. 3:2001;218-223.
12. Hirai Y., et al. Epimorphin functions as a key morphoregulator for mammary epithelial cells. J. Cell Biol. 140:1998;159-169.
13. Hirai Y., et al. Epimorphin mediates mammary luminal morphogenesis through control of C/EBPβ J. Cell Biol. 153:2001;785-794.
14. Gudjonsson T., et al. Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J. Cell Sci. 115:2002;39-50.
15. Runswick S.K., et al. Desmosomal adhesion regulates epithelial morphogenesis and cell positioning. Nat. Cell Biol. 3:2001;823-830.
16. Ronnov-Jessen L., et al. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol. Rev. 76:1996;69-125.
17. Hovey R.C., et al. Regulation of mammary gland growth and morphogenesis by the mammary fat pad: a species comparison. J. Mammary Gland Biol. Neoplasia. 4:1999;53-68.
18. Witty J.P., et al. Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Mol. Biol. Cell. 6:1995;1287-1303.
19. Sympson C.J., et al. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J. Cell Biol. 125:1994;681-693.
20. Delmas V., et al. Expression of the cytoplasmic domain of E-cadherin induces precocious mammary epithelial alveolar formation and affects cell polarity and cell-matrix integrity. Dev. Biol. 216:1999;491-506.
21. Wiseman B.S., Werb Z. Stromal effects on mammary gland development and breast cancer. Science. 296:2002;1046-1049.
22. O'Brien L.E., et al. Building epithelial architecture: insights from three-dimensional culture models. Nat. Rev. Mol. Cell Biol. 3:2002;531-537.
23. Lubarsky B., Krasnow M.A. Tube morphogenesis: making and shaping biological tubes. Cell. 112:2003;19-28.
24. Affolter M., et al. Tube or not tube. Remodeling epithelial tissues by branching morphogenesis. Dev. Cell. 4:2003;11-18.
25. Metzger R.J., Krasnow M.A. Genetic control of branching morphogenesis. Science. 284:1999;1635-1639.
26. Hogan B.L., Kolodziej P.A. Organogenesis: molecular mechanisms of tubulogenesis. Nat. Rev. Genet. 3:2002;513-523.
27. Simian M., et al. The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells. Development. 128:2001;3117-3131.
28. Hirai Y., et al. Epimorphin: a mesenchymal protein essential for epithelial morphogenesis. Cell. 69:1992;471-481.
29. Gumbiner B.M. Epithelial morphogenesis. Cell. 69:1992;385-387.
30. Bennett M.K., et al. The syntaxin family of vesicular transport receptors. Cell. 74:1993;863-873.
31. Pelham H.R. Is epimorphin involved in vesicular transport? Cell. 73:1993;425-426.
32. Hirai Y. Epimorphin as a morphogen: does a protein for intracellular vesicular targeting act as an extracellular signaling molecule? Cell Biol. Int. 25:2001;193-195.
33. Brinkmann V., et al. Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells. J. Cell Biol. 131:1995;1573-1586.
34. Zahnow C.A. CCAAT/enhancer binding proteins in normal mammary development and breast cancer. Breast Cancer Res. 4:2002;113-121.
35. Vu T.H., Werb Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev. 14:2000;2123-2133.
36. Lochter A., et al. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J. Cell Biol. 139:1997;1861-1872.
37. Mori M., Miyazaki K. Factors affecting morphogenesis of rabbit gallbladder epithelial cells cultured in collagen gels. Cell Tissue Res. 300:2000;331-344.
38. Lehnert L., et al. Autocrine stimulation of human pancreatic duct-like development by soluble isoforms of epimorphin in vitro. J. Cell Biol. 152:2001;911-922.
39. Hirose M., et al. A new function of Ito cells in liver morphogenesis: evidence using a novel morphogenic protein, epimorphin, in vitro. Biochem. Biophys. Res. Commun. 225:1996;155-160.
40. Watanabe S., et al. A novel hepatic stellate (Ito) cell-derived protein, epimorphin, plays a key role in the late stages of liver regeneration. Biochem. Biophys. Res. Commun. 250:1998;486-490.
41. Koshida S., Hirai Y. Identification of cellular recognition sequence of epimorphin and critical role of cell/epimorphin interaction in lung branching morphogenesis. Biochem. Biophys. Res. Commun. 234:1997;522-525.
42. Oka Y., Hirai Y. Inductive influences of epimorphin on endothelial cells in vitro. Exp. Cell Res. 222:1996;189-198.
43. Davies J.A. Do different branching epithelia use a conserved developmental mechanism? BioEssays. 24:2002;937-948.
44. Birchmeier C., Gherardi E. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol. 8:1998;404-410.
45. Hennighausen L., Robinson G.W. Signaling pathways in mammary gland development. Dev. Cell. 1:2001;467-475.
46. Grimm S.L., et al. Disruption of steroid and prolactin receptor patterning in the mammary gland correlates with a block in lobuloalveolar development. Mol. Endocrinol. 16:2002;2675-2691.
47. Zegers M.M., et al. Epithelial polarity and tubulogenesis in vitro. Trends Cell Biol. 13:2003;169-176.
48. Lin H.H., et al. Bcl-2 overexpression prevents apoptosis-induced Madin-Darby canine kidney simple epithelial cyst formation. Kidney Int. 55:1999;168-178.
49. Yu W., et al. Hepatocyte growth factor switches orientation of polarity and mode of movement during morphogenesis of multicellular epithelial structures. Mol. Biol. Cell. 14:2003;748-763.
50. Low S.H., et al. Retinal pigment epithelial cells exhibit unique expression and localization of plasma membrane syntaxins which may contribute to their trafficking phenotype. J. Cell Sci. 115:2002;4545-4553.
51. Low S.H., et al. Differential localization of syntaxin isoforms in polarized Madin-Darby canine kidney cells. Mol. Biol. Cell. 7:1996;2007-2018.
52. Matsuki Y., et al. Gene expression of epimorphin in rat incisor ameloblasts. Arch. Oral Biol. 40:1995;161-164.
53. Butt K.I., et al. Immunolocalization of epimorphin in skin. J. Dermatol. Sci. 13:1996;193-201.
54. Akiyama M., et al. Epimorphin expression during human foetal hair follicle development. Br. J. Dermatol. 141:1999;447-452.
55. Nagamatsu S., et al. Non-functional role of syntaxin 2 in insulin exocytosis by pancreatic beta cells. Cell Biochem. Funct. 15:1997;237-242.
56. Plateroti M., et al. Subepithelial fibroblast cell lines from different levels of gut axis display regional characteristics. Am. J. Physiol. 274:1998;G945-G954.
57. Goyal A., et al. Characterization of rat epimorphin/syntaxin 2 expression suggests a role in crypt-villus morphogenesis. Am. J. Physiol. 275:1998;G114-G124.
58. Zhang L., et al. Immunohistochemical distribution of epimorphin in human and mouse tissues. Histochem. J. 30:1998;903-908.
59. Fang K.C. Mesenchymal regulation of alveolar repair in pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 23:2000;142-145.
60. Terasaki Y. Epimorphin in bleomycin-induced pulmonary fibrosis in mice. Chest. 120:2001;30S-32S.
61. Terasaki Y., et al. Increased expression of epimorphin in bleomycin-induced pulmonary fibrosis in mice. Am. J. Respir. Cell Mol. Biol. 23:2000;168-174.
62. Horikoshi S., et al. Protein localization and mRNA expression of epimorphin in mouse and human kidneys. Exp. Nephrol. 9:2001;412-419.
63. Zhang L., et al. Influences of keratinocyte-fibroblast interaction on the expression of epimorphin by fibroblasts in vitro. J. Dermatol. Sci. 20:1999;191-196.
64. Fritsch C., et al. Epimorphin expression in intestinal myofibroblasts induces epithelial morphogenesis. J. Clin. Invest. 110:2002;1629-1641.
65. Chen Y.A., Scheller R.H. SNARE-mediated membrane fusion. Nat. Rev. Mol. Cell Biol. 2:2001;98-106.
66. Hirai Y., et al. Reexamination of the properties of epimorphin and its possible roles. Cell. 73:1993;426-427.
67. Lemons P.P., et al. Regulated secretion in platelets: identification of elements of the platelet exocytosis machinery. Blood. 90:1997;1490-1500.
68. Chen D., et al. Molecular mechanisms of platelet exocytosis: role of SNAP-23 and syntaxin 2 in dense core granule release. Blood. 95:2000;921-929.
69. Lemons P.P., et al. Molecular mechanisms of platelet exocytosis: requirements for α-granule release. Biochem. Biophys. Res. Commun. 267:2000;875-880.
70. Chen D., et al. Molecular mechanisms of platelet exocytosis: role of SNAP-23 and syntaxin 2 and 4 in lysosome release. Blood. 96:2000;1782-1788.
71. Hansen N.J., et al. Identification of SNAREs involved in regulated exocytosis in the pancreatic acinar cell. J. Biol. Chem. 274:1999;22871-22876.
72. Travis A.J., et al. Expression and localization of caveolin-1, and the presence of membrane rafts, in mouse and guinea pig spermatozoa. Dev. Biol. 240:2001;599-610.
73. Katafuchi K., et al. Localization of a syntaxin isoform, syntaxin 2, to the acrosomal region of rodent spermatozoa. Mol. Reprod. Dev. 57:2000;375-383.
74. Kierszenbaum A.L. Fusion of membranes during the acrosome reaction: a tale of two SNAREs. Mol. Reprod. Dev. 57:2000;309-310.
75. Mandon B., et al. Expression of syntaxins in rat kidney. Am. J. Physiol. 273:1997;F718-F730.
76. Quinones B., et al. Syntaxin 2 splice variants exhibit differential expression patterns, biochemical properties and subcellular localizations. J. Cell Sci. 112:1999;4291-4304.
77. Yeaman C., et al. New perspectives on mechanisms involved in generating epithelial cell polarity. Physiol. Rev. 79:1999;73-98.
78. Jahn R., Sudhof T.C. Membrane fusion and exocytosis. Annu. Rev. Biochem. 68:1999;863-911.
79. Sutton R.B., et al. Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 Å resolution. Nature. 395:1998;347-353.
80. Ohara-Imaizumi M., et al. Transduction of MIN6 b cells with TAT-syntaxin H3 domain inhibits docking and fusion of insulin granules in biphasic insulin release in a distinct mechanism analyzed by evanescent wave microscopy. J. Biol. Chem. 277:2002;50805-50811.
81. Misura K.M., et al. Three-dimensional structure of the neuronal-Sec1-syntaxin 1a complex. Nature. 404:2000;355-362.
82. Mignatti P., et al. Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J. Cell. Physiol. 151:1992;81-93.
83. Jackson A., et al. Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells. Proc. Natl. Acad. Sci. U. S. A. 89:1992;10691-10695.
84. Siders W.M., Mizel S.B. Interleukin-1 β secretion. A possible multistep process that is regulated in a cell type-specific manner. J. Biol. Chem. 270:1995;16258-16264.
85. Sesaki H., et al. The cell adhesion molecule DdCAD-1 in Dictyostelium is targeted to the cell surface by a nonclassical transport pathway involving contractile vacuoles. J. Cell Biol. 138:1997;939-951.
86. Cleves A.E., et al. A new pathway for protein export in Saccharomyces cerevisiae. J. Cell Biol. 133:1996;1017-1026.
87. Kuchler, K. et al. (1997) Unusual Secretory Pathways: From Bacteria to Man. Landes Bioscience.
88. Prochiantz A. Messenger proteins: homeoproteins, TAT and others. Curr. Opin. Cell Biol. 12:2000;400-406.
89. Prudovsky I., et al. The intracellular translocation of the components of the fibroblast growth factor 1 release complex precedes their assembly prior to export. J. Cell Biol. 158:2002;201-208.
90. Bogdanov M., et al. A polytopic membrane protein displays a reversible topology dependent on membrane lipid composition. EMBO J. 21:2002;2107-2116.
91. LaVallee T.M., et al. Synaptotagmin-1 is required for fibroblast growth factor-1 release. J. Biol. Chem. 273:1998;22217-22223.
92. Andrei C., et al. The secretory route of the leaderless protein interleukin 1β involves exocytosis of endolysosome-related vesicles. Mol. Biol. Cell. 10:1999;1463-1475.
93. Hamon Y., et al. Interleukin-1β secretion is impaired by inhibitors of the Atp binding cassette transporter, ABC1. Blood. 90:1997;2911-2915.
94. Lindstedt R., et al. Apical secretion of a cytosolic protein by Madin-Darby canine kidney cells. Evidence for polarized release of an endogenous lectin by a nonclassical secretory pathway. J. Biol. Chem. 268:1993;11750-11757.
95. Ancellin N., et al. Extracellular export of sphingosine kinase-1 enzyme. Sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation. J. Biol. Chem. 277:2002;6667-6675.
96. Powis G., Montfort W.R. Properties and biological activities of thioredoxins. Annu. Rev. Pharmacol. Toxicol. 41:2001;261-295.
97. Bertini R., et al. Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. J. Exp. Med. 189:1999;1783-1789.
98. Muller S., et al. New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal. EMBO J. 20:2001;4337-4340.
99. Haga A., et al. Phosphohexose isomerase/autocrine motility factor/neuroleukin/maturation factor is a multifunctional phosphoprotein. Biochim. Biophys. Acta. 1480:2000;235-244.
100. Sun Y.J., et al. The crystal structure of a multifunctional protein: phosphoglucose isomerase/autocrine motility factor/neuroleukin. Proc. Natl. Acad. Sci. U. S. A. 96:1999;5412-5417.
101. Assmann V., et al. The intracellular hyaluronan receptor RHAMM/IHABP interacts with microtubules and actin filaments. J. Cell Sci. 112:1999;3943-3954.
102. Tammi M.I., et al. Hyaluronan and homeostasis: a balancing act. J. Biol. Chem. 277:2002;4581-4584.
103. Liu F.T., et al. Intracellular functions of galectins. Biochim. Biophys. Acta. 1572:2002;263-273.
104. Rabinovich G.A., et al. Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? Trends Immunol. 23:2002;313-320.
105. Thomas J.O., Travers A.A. HMG1 and 2, and related 'architectural' DNA-binding proteins. Trends Biochem. Sci. 26:2001;167-174.
106. Degryse B., et al. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J. Cell Biol. 152:2001;1197-1206.
107. Wang H., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 285:1999;248-251.
108. Nakaoka H., et al. Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science. 264:1994;1593-1596.
109. Chen J.S., Mehta K. Tissue transglutaminase: an enzyme with a split personality. Int. J. Biochem. Cell Biol. 31:1999;817-836.
110. Akimov S.S., et al. Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J. Cell Biol. 148:2000;825-838.
111. Arner E.S., Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267:2000;6102-6109.